Carter Van Waes, M.D., Ph.D.
Affiliations: | NIDCD | National Institutes of Health, Bethesda, MD |
Area:
CancerGoogle:
"Carter Van Waes"Mean distance: 106866 (cluster 11)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sakakibara N, Clavijo PE, Sievers C, et al. (2023) Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis. Frontiers in Immunology. 14: 1200970 |
| Morgan EL, Toni T, Viswanathan R, et al. (2023) Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). Cell Death and Differentiation |
| Toni T, Viswanathan R, Robbins Y, et al. (2023) Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma. Cancers. 15 |
| Hu Z, Viswanathan R, Cheng H, et al. (2022) Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. Molecular Cancer Research : McR |
| Yang X, Cheng H, Chen J, et al. (2019) Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. Cancer Immunology Research |
| Das R, Coupar J, Clavijo PE, et al. (2018) Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. Molecular Carcinogenesis |
| Day TA, Shirai K, O'Brien PE, et al. (2018) Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Xiao R, Allen CT, Tran L, et al. (2018) Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. Oncoimmunology. 7: e1471440 |
| Mohan S, Vander Broek R, Shah S, et al. (2015) MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lu H, Yan C, Quan XX, et al. (2014) CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. Neoplasia (New York, N.Y.). 16: 789-800 |